Comparison of Operating Conditions, Postoperative Recovery and Overall Satisfaction Between Deep and Restricted Neuromuscular Blockade for Spinal Surgery Under General Anesthesia
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Pharmacodynamics
- 27 Mar 2017 Status changed from recruiting to completed.
- 10 Jul 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
- 10 Jul 2016 Status changed from not yet recruiting to recruiting.